Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,446,043
  • Shares Outstanding, K 31,840
  • Annual Sales, $ 1,534 M
  • Annual Income, $ 30,300 K
  • 36-Month Beta 1.00
  • Price/Sales 2.33
  • Price/Cash Flow 40.66
  • Price/Book 8.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.79
  • Number of Estimates 7
  • High Estimate 0.93
  • Low Estimate 0.72
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +41.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.51 +1.05%
on 10/22/18
127.38 -14.71%
on 10/01/18
-9.91 (-8.36%)
since 09/21/18
3-Month
92.08 +17.98%
on 07/30/18
127.38 -14.71%
on 10/01/18
+13.04 (+13.64%)
since 07/20/18
52-Week
45.60 +138.25%
on 11/01/17
127.38 -14.71%
on 10/01/18
+58.37 (+116.11%)
since 10/20/17

Most Recent Stories

More News
Amedisys to Buy Compassionate Care Hospice, Share Price Down

Amedisys (AMED) adopts initiatives to boost hospice business. It expects to become the third-largest hospice provider in America with the latest buyout.

GHDX : 65.84 (+2.24%)
AMED : 108.64 (+0.38%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)
Look for Shares of Amedisys Inc to Potentially Rebound after Yesterday's 3.00% Sell Off

Amedisys Inc (NASDAQ:AMED) traded in a range yesterday that spanned from a low of $109.69 to a high of $116.50. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $113.13...

AMED : 108.64 (+0.38%)
Quest Diagnostics Boosts Health & Wellness, Acquires Provant

Quest Diagnostics' (DGX) Provant Health acquisition is in line with its 'accelerate growth' strategy.

DGX : 101.54 (-0.94%)
AMED : 108.64 (+0.38%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)
QIAGEN Introduces New RNA-seq Library Preparation Solutions

QIAGEN (QGEN) adopts initiatives to boost the NGS portfolio.

AMED : 108.64 (+0.38%)
MASI : 115.82 (-0.13%)
QGEN : 35.58 (-0.92%)
ISRG : 511.41 (+1.42%)
Walgreens (WBA) Q4 Earnings Top Estimates, Revenues Lag

Walgreens' (WBA) Retail Pharmacy USA division witnesses comparable prescription growth and benefits from a strong retail prescription market.

AMED : 108.64 (+0.38%)
WBA : 77.65 (+0.39%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)
Louisiana hospice company buys New Jersey-based chain

BATON ROUGE, La. (AP) — A Louisiana-based home health and hospice company says it's buying a nationwide hospice company based in New Jersey, and will become the nation's third-largest hospice provider....

AMED : 108.64 (+0.38%)
BioScrip Grows on CORE Plan, Reimbursement Issues Persist

BioScrip (BIOS) progresses well on the back of its new multi-faceted CORE plan to improve its financial position.

BIOS : 2.93 (+0.34%)
AMED : 108.64 (+0.38%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)
Genomic Health's Test Gets Favored by New NCCN Guidelines

Genomic Health (GHDX) forges ahead with the development of Oncotype DX Breast Recurrence Score test.

GHDX : 65.84 (+2.24%)
AMED : 108.64 (+0.38%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)
Shares of Davita Inc Rank the Highest in Terms of Relative Performance in the Health Care Services Industry (DVA , AMED , LH , ESRX , DGX )

Below are the top five companies in the Health Care Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

AMED : 108.64 (+0.38%)
LH : 169.35 (-1.88%)
DVA : 66.99 (-0.98%)
Here's Why You Should Invest in Boston Scientific Stock Now

Boston Scientific (BSX) is coming up with better-than-expected earnings and revenue performances on the back of growth across all business lines and geographies.

AMED : 108.64 (+0.38%)
BSX : 36.62 (+0.22%)
MASI : 115.82 (-0.13%)
ISRG : 511.41 (+1.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 111.63
1st Resistance Point 110.14
Last Price 108.64
1st Support Level 107.33
2nd Support Level 106.01

See More

52-Week High 127.38
Last Price 108.64
Fibonacci 61.8% 96.14
Fibonacci 50% 86.49
Fibonacci 38.2% 76.84
52-Week Low 45.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar